NCT01049347View on ClinicalTrials.gov

Amitriptyline and Paroxetine Treatment of Major Depression

PHASE3CompletedINTERVENTIONAL
Enrollment

127

Participants

Timeline

Start Date

October 31, 1997

Primary Completion Date

May 31, 2000

Study Completion Date

May 31, 2000

Conditions
Unipolar Depression
Interventions
DRUG

amitriptyline

150 mg oral, daily, single evening dose, 35 days

DRUG

paroxetine

40 mg oral, single dose, morning, 35 days

Trial Locations (1)

68159

Central Institute of Mental Health, Mannheim

All Listed Sponsors
lead

Central Institute of Mental Health, Mannheim

OTHER

NCT01049347 - Amitriptyline and Paroxetine Treatment of Major Depression | Biotech Hunter | Biotech Hunter